PARP1 and neoplasm: Since BRCA1/2-mutant tumor cells are deficient in HR-mediated DNA repair, they are especially reliant on PARP1/2 for their survival (Bryant et al, 2005; Farmer et al, 2005; Venkitaraman, 2019).